Lindbrook Capital’s CONMED CNMD Stock Holding History

Lindbrook Capital’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$423	Hold	7	–	–	﹤0.01%	2651
2024 Q4	$479	Buy	+7	New	+$488	﹤0.01%	2632
2024 Q3	–	Sell	-70	Closed	-$4.85K	–	2840
2024 Q2	$4.85K	Buy	+70	New	+$5.11K	﹤0.01%	2005
2024 Q1	–	Sell	-37	Closed	-$4.05K	–	2667
2023 Q4	$4.05K	Sell	37 -18	-33%	-$1.86K	﹤0.01%	2000
2023 Q3	$5.55K	Buy	55 +50	+1,000%	+$5.75K	﹤0.01%	1718
2023 Q2	$679	Hold	5	–	–	﹤0.01%	2442
2023 Q1	$519	Buy	+5	New	+$484	﹤0.01%	2599
2022 Q4	–	Sell	-121	Closed	-$10K	–	2858
2022 Q3	$10K	Sell	121 -294	-71%	-$27.7K	﹤0.01%	1316
2022 Q2	$40K	Sell	415 -15	-3%	-$1.8K	0.01%	741
2022 Q1	$64K	Sell	430 -504	-54%	-$70.4K	0.01%	606
2021 Q4	$132K	Buy	+934	New	+$132K	0.02%	417

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Lindbrook Capital's CNMD Position: Q1 2025 in Review

Lindbrook Capital held its CONMED (CNMD) position steady in Q1 2025 at 7 shares worth $423. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

Lindbrook Capital first reported a position in CNMD in Q4 2021 and has held it in 11 quarters since. The position peaked at $132K in Q4 2021. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

Lindbrook Capital held 7 shares of CONMED worth $423 as of Q1 2025.
Lindbrook Capital left its CONMED share count unchanged in Q1 2025.
CONMED made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2651 holding.
Lindbrook Capital first reported a position in CONMED in Q4 2021 and has held it in 11 quarters since.
Lindbrook Capital's CONMED position peaked at $132K in Q4 2021.
280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.